文献速递关节外科小儿骨科

儿童患者全髋关节置换术:平均5.3年随访的单中心经验

Pediatric Patients Undergoing Total Hip Arthroplasty: A Single-Center Experience at Average 5.3-Year Follow-Up.
PubMed 文献 · J Arthroplasty · 2025-03-17

该单中心病例系列纳入2013至2023年间由同一资深术者完成的74例21岁以下患者共92例全髋关节置换术,平均随访5.3年。最常见病因为Perthes病和糖皮质激素诱导的骨坏死(各占15.2%)。术后患者报告结局指标均显著改善,5年和10年无翻修Kaplan-Meier生存率均为98.9%。

要点

  • 21岁以下患者全髋关节置换术后5年功能结局显著改善。
  • 5年和10年无翻修Kaplan-Meier生存率均为98.9%。
  • 仅1例(1.1%)因无菌性松动行股骨翻修。

核心结论

  • 21岁以下患者全髋关节置换术在5年功能结局方面带来实质性改善,与病因无关,翻修率极低且假体生存率优异。

研究设计与样本

  • 单中心病例系列,经机构审查委员会批准,纳入2013至2023年间74例21岁以下患者共92例全髋关节置换术,由同一资深术者完成。
  • 平均随访5.3年(范围1至11.2年),手术时平均年龄16岁(范围11至21岁),无患者失访。

主要发现

  • 最常见病因为Perthes病和糖皮质激素诱导的骨坏死,各占15.2%。
  • 1例(1.1%)IV型黏多糖贮积症患者因无菌性松动需行股骨翻修,无其他患者翻修。
  • 术后所有平均患者报告结局指标显著改善(P < 0.00001):髋关节功能障碍与骨关节炎结局评分-关节置换版从53.4(四分位距46.7至70.4)提高至89.9(四分位距85.3至100)。
  • 术后所有平均患者报告结局指标显著改善(P < 0.00001):EQ-5D从0.5(四分位距0.2至0.7)提高至0.8(四分位距0.7至1)。
  • 术后所有平均患者报告结局指标显著改善(P < 0.00001):EQ视觉模拟量表从81(四分位距70至95)提高至85(四分位距80至100)。

关键数值与推荐

  • 5年和10年无翻修Kaplan-Meier生存率均为98.9%。
  • 92.4%采用后入路,7.6%采用前入路;90.2%使用陶瓷对高交联聚乙烯轴承,其余9.8%使用金属股骨头。
  • 所有患者均根据股骨形态选择非骨水泥股骨柄。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total hip arthroplasty (THA) is an increasingly popular option for pediatric end-stage hip disease. However, data regarding implant longevity and functional outcomes remain limited. This case series evaluated complication and revision rates, patient-reported outcome measures (PROMs), and implant survivorship in consecutive pediatric THA patients from a single surgeon. We hypothesized that pediatric patients would have low revision rates and excellent functional outcomes at 5-year follow-up. METHODS: Following institutional review board approval, 74 patients under age 21 years who underwent 92 THAs between 2013 and 2023 were identified. Age, etiology, follow-up interval, complications, revisions, and preoperative and postoperative PROMs were recorded. The mean follow-up was 5.3 years (range, one to 11.2) and mean age at surgery was 16 years (range, 11 to 21). All patients underwent THA by the senior surgeon through a posterior (92.4%) or anterior (7.6%) approach; 90.2% received a ceramic on a highly cross-linked polyethylene bearing, with the remaining 9.8% receiving a metal femoral head. All patients received a cementless stem based on femoral morphology. No patients were lost to follow-up. RESULTS: The most common etiologies were Perthes disease and corticosteroid-induced osteonecrosis (15.2% each). A patient (1.1%) with Mucopolysaccharidosis type IV required a femoral revision for aseptic loosening; no other patients were revised. All average postoperative PROMs improved significantly (P < 0.00001): Hip Disability and Osteoarthritis Outcome Score, Joint Replacement 53.4 (interquartile range [IQR], 46.7 to 70.4) to 89.9 (IQR, 85.3 to 100), EQ-5D 0.5 (IQR, 0.2 to 0.7) to 0.8 (IQR, 0.7 to 1), and EQ visual analog scale 81 (IQR, 70 to 95) to 85 (IQR, 80 to 100). Revision-free Kaplan-Meier survivorship at 5 and 10 years was 98.9%. CONCLUSIONS: Total hip arthroplasty (THA) in patients under age 21 years yields substantial improvements in 5-year functional outcomes, regardless of etiology, with extremely low revision rates and excellent implant survivorship.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hong JX, Dravid A, Sankar WN, et al. Pediatric Patients Undergoing Total Hip Arthroplasty: A Single-Center Experience at Average 5.3-Year Follow-Up. J Arthroplasty. 2025. PMID: 40107578. doi:10.1016/j.arth.2025.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。